{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:34:41Z","timestamp":1777415681422,"version":"3.51.4"},"reference-count":50,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[1982,12,1]],"date-time":"1982-12-01T00:00:00Z","timestamp":407548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Intelligence &amp; Clinical Pharmacy"],"published-print":{"date-parts":[[1982,12]]},"abstract":"<jats:p>Cinoxacin, a synthetic organic acid antibacterial agent, related structurally to nalidixic and oxolinic acid, has been approved for the treatment of initial and recurrent urinary tract infections (UTIs) caused by susceptible gram-negative microorganisms. The role of cinoxacin in the treatment of UTIs, compared with the usual first-line agents, is uncertain at this time. The efficacy of cinoxacin in the treatment of pyelonephritis, compared with these proven agents, has been examined in only small numbers of patients, and cinoxacin is more expensive than these agents. Cinoxacin may prove valuable in the treatment of prostatitis and in the prophylaxis of recurrent UTIs; further study in these areas is warranted. In the routine treatment of acute UTIs, cinoxacin perhaps should be reserved only for those patients with organisms resistant to usual first-line agents or those who fail to respond to therapy with these agents. In this respect, cinoxacin may, in the future, replace nalidixic acid.<\/jats:p>","DOI":"10.1177\/106002808201601203","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T11:35:22Z","timestamp":1462966522000},"page":"916-921","source":"Crossref","is-referenced-by-count":2,"title":["Cinoxacin (Cinobac, Eli Lilly &amp; Co.)"],"prefix":"10.1177","volume":"16","author":[{"given":"David R.P.","family":"Guay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1982,12,1]]},"reference":[{"key":"bibr1-106002808201601203","volume-title":"Clinical pharmacology of cinoxacin. Information for clinical investigators","author":"Lilly Research Laboratories.","year":"1980"},{"key":"bibr2-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.7.5.688"},{"key":"bibr3-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1976.tb10183.x"},{"key":"bibr4-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1128\/JB.89.4.1068-1074.1965"},{"key":"bibr5-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1038\/260643a0"},{"key":"bibr6-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1128\/JB.95.5.1622-1626.1968"},{"key":"bibr7-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/4.1.73"},{"key":"bibr8-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.7.3.370"},{"key":"bibr9-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.7.2.159"},{"key":"bibr10-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/5.4.413"},{"key":"bibr11-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.11.4.577"},{"key":"bibr12-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.4.4.415"},{"key":"bibr13-106002808201601203","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jac\/3.5.411","volume":"3","author":"Mardh PA","year":"1977","journal-title":"J Antimicrob Chemother"},{"key":"bibr14-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.10.1.146"},{"key":"bibr15-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.10.6.918"},{"key":"bibr16-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.15.2.165"},{"key":"bibr17-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/3.6.579"},{"key":"bibr18-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.16.3.411"},{"key":"bibr19-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1977.tb04089.x"},{"key":"bibr20-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.9.3.502"},{"key":"bibr21-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1978.tb01577.x"},{"key":"bibr22-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.15.3.465"},{"key":"bibr23-106002808201601203","first-page":"119","volume":"19","author":"Wolen RL","year":"1976","journal-title":"Clin Pharmacol Ther"},{"key":"bibr24-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/4.5.451"},{"key":"bibr25-106002808201601203","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/clpt.1980.66","volume":"27","author":"Affrime MB","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"bibr26-106002808201601203","first-page":"632","volume":"14","author":"Blanford MF","year":"1980","journal-title":"Drug Intell Clin Pharm"},{"key":"bibr27-106002808201601203","first-page":"417","volume-title":"Chemotherapy, volume 5: Penicillins and cephalosporins","author":"Bennett AH","year":"1975"},{"key":"bibr28-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(77)90157-1"},{"key":"bibr29-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)55775-4"},{"key":"bibr30-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)57104-9"},{"key":"bibr31-106002808201601203","first-page":"1041","volume-title":"Current chemotherapy","volume":"2","author":"Welles JS","year":"1978"},{"key":"bibr32-106002808201601203","first-page":"696","volume-title":"Current chemotherapy","volume":"1","author":"Santos M","year":"1978"},{"key":"bibr33-106002808201601203","first-page":"697","volume-title":"Current chemotherapy","volume":"1","author":"Exaire E.","year":"1978"},{"key":"bibr34-106002808201601203","first-page":"207","volume":"11","author":"Jones GW","year":"1980","journal-title":"J Fam Pract"},{"key":"bibr35-106002808201601203","first-page":"693","volume-title":"Current chemotherapy","volume":"1","author":"Elo J","year":"1978"},{"key":"bibr36-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(81)90070-4"},{"key":"bibr37-106002808201601203","first-page":"700","volume-title":"Current chemotherapy","volume":"1","author":"Drylie DM","year":"1978"},{"key":"bibr38-106002808201601203","first-page":"699","volume-title":"Current chemotherapy","volume":"1","author":"Wilson P.","year":"1978"},{"key":"bibr39-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)55219-2"},{"key":"bibr40-106002808201601203","first-page":"702","volume-title":"Current chemotherapy","volume":"1","author":"Klastersky J","year":"1978"},{"key":"bibr41-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)55220-9"},{"key":"bibr42-106002808201601203","first-page":"704","volume-title":"Current chemotherapy","volume":"1","author":"Lindan R.","year":"1978"},{"key":"bibr43-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(81)90207-7"},{"key":"bibr44-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196611172752001"},{"key":"bibr45-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1976.03270170023019"},{"key":"bibr46-106002808201601203","doi-asserted-by":"publisher","DOI":"10.3109\/inf.1974.6.issue-3.09"},{"key":"bibr47-106002808201601203","first-page":"A291","volume":"48","author":"Howard LC","year":"1979","journal-title":"Toxicol Appl Pharmacol"},{"key":"bibr48-106002808201601203","first-page":"1071","volume":"36","author":"Gleckman R","year":"1979","journal-title":"Am J Hosp Pharm"},{"key":"bibr49-106002808201601203","first-page":"1077","volume":"36","author":"Gleckman R","year":"1979","journal-title":"Am J Hosp Pharm"},{"key":"bibr50-106002808201601203","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600680227"}],"container-title":["Drug Intelligence &amp; Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002808201601203","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002808201601203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:00:26Z","timestamp":1777374026000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/106002808201601203"}},"subtitle":[],"editor":[{"given":"Eric A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Alex A.","family":"Cardoni","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[1982,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1982,12]]}},"alternative-id":["10.1177\/106002808201601203"],"URL":"https:\/\/doi.org\/10.1177\/106002808201601203","relation":{},"ISSN":["0012-6578"],"issn-type":[{"value":"0012-6578","type":"print"}],"subject":[],"published":{"date-parts":[[1982,12]]}}}